Transgene Biotek Management
Management criteria checks 2/4
Transgene Biotek's CEO is Koteswara Kanuru, appointed in Mar 2020, has a tenure of 4.67 years. directly owns 21.65% of the company’s shares, worth ₹106.79M. The average tenure of the management team and the board of directors is 5.5 years and 7.3 years respectively.
Key information
Koteswara Kanuru
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 4.7yrs |
CEO ownership | 21.6% |
Management average tenure | 5.5yrs |
Board average tenure | 7.3yrs |
Recent management updates
Recent updates
CEO
Koteswara Kanuru (82 yo)
4.7yrs
Tenure
Dr. Koteswara Rao Kanuru serves as the Managing Director of Transgene Biotek Limited since March 4, 2020 and served as its Compliance Officer since May 29, 2015. Dr. Kanuru served as the Compliance Officer...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & MD | 4.7yrs | no data | 21.65% ₹ 106.8m | |
Chief Financial Officer | 5.5yrs | ₹456.00k | no data | |
Company Secretary & Compliance Officer | 5.5yrs | ₹240.00k | no data |
5.5yrs
Average Tenure
Experienced Management: 526139's management team is seasoned and experienced (5.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & MD | 13.2yrs | no data | 21.65% ₹ 106.8m | |
Non-Executive Independent Woman Director | 9.6yrs | ₹20.00k | no data | |
Non-Executive Independent Director | 5yrs | ₹20.00k | no data | |
Independent Director | 4.4yrs | ₹20.00k | no data |
7.3yrs
Average Tenure
41yo
Average Age
Experienced Board: 526139's board of directors are considered experienced (7.3 years average tenure).